This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Prothena last week said it has abandoned its lead product after a Phase 3 amyloi...
An Indianapolis-headquartered biotech reentered the neuroscience scene with more...
When Lucas Siow and his three fellow co-founders started ProteinQure in 2017, th...
Protein degrader shop GlycoEra, spun out of vaccines company LimmaTech in 2021, ...
The Column Group's drug R&D team, known as TCG Labs Soleil, has been busy churni...
Welcome back to another edition of Endpoints Weekly. We had another busy week ch...
President Donald Trump unofficially asked CMS Administrator Mehmet Oz to lead th...
Nearly one out of every 20 staff in the FDA offices that oversee drugs and biolo...
The US Customs and Border Protection warned drugmakers against trying to evade i...
Plus, news about Sanofi, Servier, BioNova, Arcutis, Roche, Satellos Bioscience, ...
GSK, Roche and SpringWorks Therapeutics were among those that secured a positive...
Kura Oncology said one-quarter of patients with certain forms of advanced acute ...
Plus, news about Sanofi, Servier, BioNova, Arcutis, Roche, Satellos Bioscience, ...
The Trump administration has been barred from carrying out its sweeping plan to ...
Gilead’s Trodelvy has passed another late-stage test in certain patients with me...
Geoffrey Porges, a longtime biotech analyst and well-known Wall Street figure, s...